New Report Calls for Emergency Funding to Combat Drug-Resistant Superbugs

The World Health Organization (WHO) has released a critical report highlighting the alarming lack of new antibiotics in the global research pipeline. The report warns that the current development rate is insufficient to tackle the rising threat of antimicrobial resistance (AMR), labeling it a silent pandemic. The WHO is calling for a global emergency fund and a push for innovative public-private partnerships to incentivize pharmaceutical companies to develop new drugs. The crisis threatens to revert medicine to a pre-antibiotic era, making routine infections and minor surgeries life-threatening again.